DABRAFENIB vs RELUGOLIX: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DABRAFENIB vs RELUGOLIX: Safety Overview
| Metric | DABRAFENIB | RELUGOLIX |
|---|---|---|
| Total FAERS Reports | 19,305 | 20,660 |
| Deaths Reported | 4,165 | 958 |
| Death Rate | 21.6% | 4.6% |
| Hospitalizations | 5,325 | 1,699 |
| Average Patient Age | 58.3 yrs | 72.4 yrs |
| % Female Patients | 48.0% | 1.4% |
| FDA Approval Date | Mar 16, 2023 | Dec 18, 2020 |
| Manufacturer | Novartis Pharmaceuticals Corporation | Sumitomo Pharma America, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |